Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
brain tumor
Research
Potential brain tumor pill shrinks tumors in mice
The compound attacked the animals’ glioblastoma by hitting a target previously thought to be difficult, if not impossible, to successfully drug.
Darren Incorvaia
Jan 28, 2026 2:00pm
Gene therapies to guns? Italian biotech makes surprise pivot
Jan 27, 2026 9:33am
SandboxAQ, iOncologi partner to create brain cancer vaccine
Jul 16, 2025 10:58am
Merck snaps up preclinical DNA biotech for $1.3B biobucks
Oct 23, 2024 7:05am
DeepGlioma AI classifies brain tumors within 90 seconds: study
Mar 27, 2023 8:15am
Servier’s $1.8B bet on Agios delivers phase 3 brain tumor win
Mar 14, 2023 10:15am
